SCHEMBL16840474

SCHEMBL16840474

CC(=O)[C@@H](C)CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
BTN3A1 O00481 1/20 0.31
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5027924 0.84 GABRR1 (0.34) BTN3A1
SCHEMBL9364993 0.84 GABRR1 (0.34) BTN3A1
SCHEMBL5027923 0.84 GABRR1 (0.34) BTN3A1
SCHEMBL26478528 0.82
SCHEMBL30664718 0.82
SCHEMBL2670209 0.81 BTN3A1 (0.35) BTN3A1
SCHEMBL1751319 0.81 BTN3A1 (0.35) BTN3A1
SCHEMBL2670343 0.81 BTN3A1 (0.35) BTN3A1
SCHEMBL22025160 0.79
SCHEMBL16820643 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175530-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. 2015-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175530-A1 ANTIBACTERIAL AGENTS MRPL21, ABCB11, LSS TSHR 4007/4885BTN3A1 4422/4885MAPT 4489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.